bispecific antibody

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Elranatamab, Myeloma, Multiple Myeloma Trial in China (Elranatamab)

Recruiting
  • Elranatamab
  • +10 more
  • Fuzhou, Fujian, China
  • +18 more
Jan 18, 2023